Cyclo3pss

Cyclo3pss Current Assets

The Current Assets of Cyclo3pss (CYPS) as of Oct 29, 2026 is 70,000.00 USD. In the previous year, Current Assets was 110,000.00 USD — a change of -36.36% (lower).

Current Assets

70,000.00USD

YoY

-36.36%

Last updated:

Current Assets of Cyclo3pss is 2002 70,000.00 USD. Current Assets of Cyclo3pss was 2001 110,000.00 USD. It decreases by -36.36% lower compared to the previous year.

The Cyclo3pss Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 1995
1.74 M USD
Jan 1, 1996
780,000.00 USD
Jan 1, 1997
1.58 M USD
Jan 1, 1998
910,000.00 USD
Jan 1, 1999
115,348.00 USD
Jan 1, 2000
87,930.00 USD
Jan 1, 2001
110,000.00 USD
Jan 1, 2002
70,000.00 USD
The Cyclo3pss Current Assets history
YEARCurrent AssetsYoY
70,000.00USD-36.36%
110,000.00USD+25.10%
87,930.00USD-23.77%
115,348.00USD-87.32%
910,000.00USD-42.41%
1.58 MUSD+102.56%
780,000.00USD-55.17%
1.74 MUSD-64.20%
4.86 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cyclo3pss Stock analysis

What does Cyclo3pss do? Cyclo3pss Corp licenses its proprietary technologies to partners with suitable resources and infrastructure to commercialize specific products. The company's principal technology addresses food safety, healthcare sanitizing, and laundry disinfection. Its products include Ster-O3-Zone, a medical sterilizer for the medical and pharmaceutical industries, Eco Wash, laundry equipment for hotels, nursing homes, and institutional markets, and Eco Pure, which applies ozone to sanitize turkey, beef, and pork carcasses as well as brine in cured meat products. Partners with existing infrastructure in these sectors purchase the licensing rights to deploy these technologies. Ster-O3-Zone targets medical and pharmaceutical markets, while Eco Wash serves institutional clients like hotels and nursing homes. Eco Pure focuses on meat processing applications, including carcass sanitization and brine treatment. The company generates revenue through licensing agreements, enabling partners to integrate these technologies into their existing operations without developing them in-house. The firm's licensing model allows partners to leverage Cyclo3pss Corp's proprietary technology in their respective markets. Partners include entities with resources to commercialize the technologies, such as those in healthcare, food processing, and institutional services. Cyclo3pss Corp does not sell products directly but earns income by granting licenses to these partners for specific applications. Cyclo3pss is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cyclo3pss stock

Current Assets of Cyclo3pss is 70,000.00 USD in 2002.

Current Assets of Cyclo3pss changed from 110,000.00 USD to 70,000.00 USD, representing a -36.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Cyclo3pss since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Cyclo3pss historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Cyclo3pss

All Key Metrics — Cyclo3pss